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Background: Protein kinase B (PKB) is activated by phosphorylation of Thr308
and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent
protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates
Ser473 (provisionally termed PDK2) is unknown. 
Results: The kinase domain of PDK1 interacts with a region of protein kinase
C-related kinase-2 (PRK2), termed the PDK1-interacting fragment (PIF). PIF is
situated carboxy-terminal to the kinase domain of PRK2, and contains a
consensus motif for phosphorylation by PDK2 similar to that found in PKBα,
except that the residue equivalent to Ser473 is aspartic acid. Mutation of any of
the conserved residues in the PDK2 motif of PIF prevented interaction of PIF
with PDK1. Remarkably, interaction of PDK1 with PIF, or with a synthetic
peptide encompassing the PDK2 consensus sequence of PIF, converted PDK1
from an enzyme that could phosphorylate only Thr308 of PKBα to one that
phosphorylates both Thr308 and Ser473 of PKBα in a manner dependent on
phosphatidylinositol (3,4,5) trisphosphate (PtdIns(3,4,5)P3). Furthermore, the
interaction of PIF with PDK1 converted the PDK1 from a form that is not directly
activated by PtdIns(3,4,5)P3 to a form that is activated threefold by
PtdIns(3,4,5)P3. We have partially purified a kinase from brain extract that
phosphorylates Ser473 of PKBα in a PtdIns(3,4,5)P3-dependent manner and
that is immunoprecipitated with PDK1 antibodies.
Conclusions: PDK1 and PDK2 might be the same enzyme, the substrate
specificity and activity of PDK1 being regulated through its interaction with
another protein(s). PRK2 is a probable substrate for PDK1.
Background
The first steps in insulin signal transduction lead to the
activation of phosphoinositide (PI) 3-kinase and the for-
mation of phosphatidylinositol (3,4,5) trisphosphate
(PtdIns(3,4,5)P3) at the plasma membrane [1–3], which
can then be converted to PtdIns(3,4)P2 [4] or to
PtdIns(4,5)P2 [5,6] by specific phosphatases. It has been
established that PtdIns(3,4,5)P3 (and/or PtdIns(3,4)P2) is a
key second messenger for insulin signalling (reviewed in
[1–3]). Protein kinase B (PKB, also known as Akt) is
rapidly activated in response to insulin and its activation is
prevented by inhibitors of PI 3-kinase [7]. Further studies
have revealed that PKB is likely to mediate many of the
effects of insulin in cells, including the stimulation of
glycogen synthesis in skeletal muscle [8], the stimulation
of glycolysis in cardiac muscle [9] and certain effects that
insulin has on protein synthesis [10–12].
PKB contains an amino-terminal pleckstrin-homology (PH)
domain followed by a kinase catalytic domain and then a
carboxy-terminal tail. The catalytic domain of PKB belongs
to the AGC subfamily of protein kinase domains (where
AGC is short for ‘the cyclic AMP-dependent protein kinase,
cyclic GMP-dependent protein kinase and protein kinase C
family) and was originally identified because of its similarity
to that of protein kinase C (PKC) isoforms and protein
kinase A (PKA) [13]. Recent work has led to a greater
understanding of the mechanism by which PKB is acti-
vated. PKB interacts (through its PH domain) with
PtdIns(3,4,5)P3, the product of PI 3-kinase activation. This
results in the translocation of PKB to the plasma membrane
but does not directly stimulate PKB activity [2,3,13].
Instead, PKB is activated at the membrane by the phospho-
rylation of two residues, Thr308 and Ser473. Both of these
residues need to be phosphorylated for maximal activation
of PKB, and their phosphorylation in vivo is prevented by
inhibitors of PI 3-kinase [14]. Thr308 is located between
subdomains VII and VIII of the kinase domain, a region in
which many kinases that are activated by phosphorylation
are phosphorylated. Ser473 is located carboxy-terminal to
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the catalytic domain, in a region that nevertheless displays
high homology between different AGC family members.
Interestingly, other members of the AGC subfamily of
protein kinases, including p70 S6 kinase [15], PKC isoforms
[16] and the serum-and glucocorticoid-inducible kinase
(SGK) [17,18] also possess residues lying in equivalent
sequences to Thr308 and Ser473 of PKB, and phosphoryla-
tion of these residues is necessary for activation of these
kinases in vivo. The residues equivalent to Thr308 lie in a
Thr–Phe–Cys–Gly–Thr–Xaa–Glu–Tyr consensus motif
(where the italicised Thr corresponds to Thr308 and Xaa is
a variable residue). The residues surrounding Ser473 lie in a
Phe–Xaa–Xaa–Phe–Ser/Thr–Phe/Tyr consensus motif. We
[19,20] and others [21,22] have identified a protein kinase
termed 3-phosphoinositide-dependent protein kinase-1
(PDK1) which, in the presence of PtdIns(3,4,5)P3 or
PtdIns(3,4)P2, phosphorylates PKB at Thr308. Subsequent
work has also shown that PDK1 phosphorylates the equiva-
lent residues on PKC isoforms [23–25], p70 S6 kinase
[26,27], SGK [17] and PKA [28]. The finding that PDK1
does not phosphorylate PKB significantly at Ser473, in vitro
or in cotransfection experiments, suggested that a distinct
protein kinase, which has provisionally been termed PDK2,
might catalyse this reaction [19]. Here, we present findings
that indicate this might not be the case. In particular, we
demonstrate that PDK1 can be converted to a form that
phosphorylates both Ser473 and Thr308 via interaction with
a small peptide corresponding to the carboxy-terminal
region of protein kinase C-related protein kinase-2 (PRK2).
These observations suggest that PDK1 and PDK2 may be
the same enzyme, the specificity of PDK1 towards Thr308
and Ser473 being regulated through its interaction with
other cellular components. 
Results
The carboxy-terminal region of PRK2 interacts specifically
with PDK1
A yeast two-hybrid screen was carried out to identify pro-
teins expressed in human skeletal muscle that interact
with PDK1. We identified a clone corresponding to the
carboxy-terminal 77 amino acids of PRK2 that yielded a
positive interaction with full-length PDK1 as well as with
the isolated kinase domain (residues 51–404), but not with
the PH domain of PDK1 (Figure 1a–d). We have termed
this region of PRK2 the ‘PDK1-interacting fragment’
(PIF). PRK2 is a Rho-dependent and lipid-dependent
protein kinase [29,30] that, like PDK1 and PKB, belongs
to the AGC subfamily of protein kinases. The PIF region
in PRK2 lies immediately carboxy-terminal to the kinase
catalytic domain, in a region where there is high sequence
homology between members of the AGC subfamily
(Figure 1e). Most notably, the carboxyl terminus of PIF
contains the consensus sequence for PDK2 phosphoryla-
tion (Phe–Xaa–Xaa–Phe–Ser/Thr–Phe/Tyr), except that
in PRK2 the Ser/Thr residue equivalent to Ser473 of PKB
is replaced with a negatively charged aspartic acid residue
(Asp978), perhaps mimicking a phosphorylated state.
In order to confirm that PDK1 interacted with PIF, we
expressed PIF as a glutathione-S-transferase (GST) fusion
protein in 293 cells (human embryonic kidney cells)
together with Myc-epitope-tagged PDK1. The cells were
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Figure 1
Two-hybrid interaction of PIF with the kinase
domain of PDK1. (a) Yeast were
transformed with a pGAD10 plasmid (LEU2)
harbouring the carboxy-terminal 77 amino
acids of PRK2 (termed PIF) in the presence
of either a pAS2-1 plasmid (TRP1) coding
for the expression of the wild-type PDK1, the
kinase domain of PDK1 (∆PH-PDK1;
residues 1–404) or the PH domain of PDK1
(residues 428–556) or the empty pAS2-1
vector as a control (denoted by –). The
position on the plate of each yeast strain is
indicated. In (b) the yeast are grown on SD
Leu- and Trp-deficient media in which all the
strains of yeast are capable of growing,
whether or not PIF is interacting with PDK1.
An interaction between PIF and PDK1 leads
to the expression of reporter genes coding
for URA3 and HIS1 that will enable growth
on (c) SD –Leu –Trp –Ura –His +3-AT
medium and (d) induction of β-galactosidase
gene expression. (e) Alignment of the amino-
acid sequence of the carboxy-terminal 77
amino acids of PRK2 with the equivalent
region of AGC subfamily kinases indicated.
Identical residues are denoted by white
letters on black background, and similar
residues by grey background.
(d)
Region A Region B
PRK2   908 EDVKKHPFFRLIDWSALMDKKVKPPFIPTIRGREDVSNFDDEFTSEAPILTPP--REPRILSEEEQEM---FRDFDYIADWC
PRK1     403 EDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPP--RDARPLTAAEQAA---FLDFDFVAGGC
PKBα 400 KEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRP—-HFPQFSYSASTA 
p70 S6K 321 GEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP----DDSTLSESANQV---FLGFTYVAPSV 
SGK      347 MEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNELRHFDPEFTEEPVPNSIGKSPDSVLVTASVKEAAEAFLGFSYAPPTD 
PKCζ 510 SDIKSHAFFRSIDWDLLEKKQALPPFQPQITDDYGLDNFDTQFTSEPVQLTPD---DEDAIKRIDQSE---FEGFEYINPLL 
PKCα 589 RDVREHAFFRRIDWEKLENREIQPPFKPKVCG-KGAENFDKFFTRGQPVLTPP---DQLVIANIDQSD---FEGFSYVNPQF 
PKAβ 290 SDIKTHKWFATTDWIAIYQRKVEAPFIPKFGRSGDTSNFDDYEEEDIRV----------SITECAKEK---FGEF        
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lysed and the GST–PIF fusion protein purified by affinity
chromatography on glutathione–Sepharose (Figure 2a), or
the Myc–PDK1 isolated by immunoprecipitation using an
anti-Myc antibody (Figure 2b). The samples were elec-
trophoresed on an SDS–polyacrylamide gel and the pro-
teins visualised by staining with Coomassie blue (Figure 2).
A near-stoichiometric complex was observed between the
GST–PIF fusion protein and wild-type PDK1, with the
isolated kinase domain of PDK1 or with a catalytically inac-
tive mutant. The complex formed between PDK1 and
GST–PIF could not be dissociated by lithium bromide (a
strong chaotrophic agent)  at concentrations up to 2 M or by
incubation with 1% (by volume) Triton X-100 (data not
shown), indicating a very strong interaction. No interaction
was observed either between GST and PDK1 (Figure 2) or
between GST–PIF and epitope-tagged PKB, p70 S6
kinase or 6-phosphofructo-2-kinase when each of these was
coexpressed with PIF in 293 cells (data not shown). Analy-
sis of the interaction using surface plasmon resonance con-
firmed that the GST–PIF fusion protein was capable of
associating directly with purified His-tagged PDK1 with an
estimated equilibrium dissociation constant of 600 nM (see
Supplementary material published with this paper on the
internet). No association between GST–PIF and
His–PKBα was detected using this method.
PIF binds specifically to the endogenous PDK1 in 293 cells
GST–PIF purified from 293 cells was found to be associ-
ated with the endogenous PDK1 as judged by western
blotting. In 293 cells, two PDK1 immunoreactive bands
were observed, at 63 kDa and 66 kDa, and both were
observed to copurify with GST–PIF (Figure 2c).The
PDK1 associated with GST–PIF (0.5 µg) was active
because in the presence of Mg–ATP and PtdIns(3,4,5)P3 it
greatly activated a GST–S473D PKBα mutant (Figure 2c).
Thus, PDK1 bound to PIF can phosphorylate PKB at
Thr308, and the interaction between PIF and the kinase
domain of PDK1 does not interfere with the activation of
PKB. In contrast, PKB, p70 S6 kinase, p90 ribosomal S6
kinase 1 (RSK1) or mitogen- and stress-activated protein
kinase 1 (MSK1), when expressed in 293 cells as GST
fusion proteins, were not associated with any endogenous
PDK1 after their precipitation on glutathione–Sepharose,
as judged by immunoblotting and failure to activate
GST–S473D PKBα (Figure 2c).
The ‘PDK2 substrate motif’ mediates the interaction
between PIF and PDK1
We have termed the amino-terminal 53 residues of PIF
‘region A’ and the carboxy-terminal 24 residues ‘region B’
(Figure 1e). In order to identify the amino-acid residues in
PIF that were required for the interaction of PIF with
PDK1, we mutated many of the residues in PIF that are
conserved between the AGC subfamily of protein kinases
Research Paper  Acquisition of PDK2 activity by PDK1 Balendran et al.    395
Figure 2
Specific interaction of GST–PIF with PDK1 in 293 cells. (a,b) Cells were
transiently transfected with DNA constructs expressing GST or GST–PIF
together with either wild-type Myc–PDK1, catalytically inactive (kinase-
dead) Myc–PDK1 (K111A, D223A) or the kinase domain of Myc–PDK1
(residues 51–404). The cells were lysed (36 h post transfection) and the
GST or GST–PIF purified from 350 µg of lysate by (a) affinity
chromatography of the lysate on glutathione–Sepharose beads or (b) the
Myc–PDK1 proteins immunoprecipitated using anti-Myc antibodies
covalently attached to protein-G–Sepharose. The total protein from each
purification was electrophoresed on a 10% SDS–polyacrylamide gel and
stained with Coomassie blue. The position of the molecular mass
markers, glycogen phosphorylase (97 kDa), bovine serum albumin
(67 kDa) and ovalbumin (43 kDa) are indicated. (c) Cells were transiently
transfected with DNA constructs expressing either GST–PIF, GST alone,
GST–p90RSK1, GST–MSK1, GST–p70 S6 kinase (p70 S6K) lacking
the carboxy-terminal 104 residues, or GST–PKBα. The cells were lysed
36 h post transfection and the GST fusion proteins purified by affinity
chromatography on glutathione–Sepharose beads. Each GST fusion
protein (2 µg) was incubated for 30 min at 30°C with
GST–S473D PKBα and Mg–ATP in the presence or absence of
phospholipid vesicles containing 10 µM 1,2-SAD-PtdIns(3,4,5)P3, and
the increase in specific activity of GST–S473D PKBα was determined
relative to a control incubation in which the GST–S473D PKBα fusion
protein was omitted (average for six determinations, three independent
experiments). The basal activity of GST–S473D PKBα was 3.5 U/mg.
Each protein (2 µg) was electrophoresed on a 10% SDS–polyacrylamide
gel and immunoblotted with an antibody raised against the PDK1 protein
to detect any endogenous PDK1 associated with the
glutathione–Sepharose pull downs.
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to alanine. The mutant GST–PIF proteins were expressed
in 293 cells at similar levels, and the amount of endoge-
nous PDK1 activity and PDK1 protein associated with
each of the purified constructs was determined (Figure 3a).
Mutation of the conserved residues in region A did not
prevent the association of PDK1 with GST–PIF. Remark-
ably, however, mutation to alanine of any of the conserved
aromatic residues in the PDK2 phosphorylation site motif
in region B (Phe974, Phe977 and Tyr979) completely abol-
ished the association of endogenous PDK1 with these
GST–PIF mutants (Figure 3a). Furthermore, mutation of
Asp978 (the residue equivalent to Ser473 in PKB) to either
alanine or serine also abolished the association of PDK1
with PIF. In contrast, mutation of the residues located two
and three amino acids amino-terminal to Asp978 (Asp976
or Arg975), which are not conserved between the AGC
subfamily members, did not affect the association of PDK1
with PIF (Figure 3a). A yeast two-hybrid screen was also
used to verify these findings (Figure 3b).
A strong interaction (Kd 800 nM) between His–PDK1 and
an immobilised and biotinylated 24 residue synthetic
peptide corresponding to region B was detected using
surface plasmon resonance measurements. This interac-
tion was competed by the addition of free peptide, and
analysis of this competition revealed a Kd of 1.5 µM. In
contrast, the interaction between PDK1 and a mutant
peptide in which the residue corresponding to Asp978 was
changed to alanine (termed D978A region B peptide)
interacted with PDK1 more than tenfold less strongly (see
Supplementary material). Incubation of purified
GST–PIF expressed in 293 cells with the wild-type
region B peptide (100 µM) resulted in dissociation of the
endogenous PDK1 from GST–PIF, whereas a D978A
region B peptide was incapable of inducing the dissocia-
tion of PDK1 from PIF (data not shown).
GST–PIF converts PDK1 to a form that is able to
phosphorylate Ser473 as well as Thr308 in PKBα
When purified GST–PIF associated with the endogenous
PDK1 of 293 cells (Figure 2c) was incubated with
GST–PKBα in the presence of Mg–ATP and
PtdIns(3,4,5)P3, we noticed that GST–PKBα could be
activated to a threefold higher maximum specific activity
(about 90 U/mg) than is achievable by incubation of
GST–PKBα with far higher concentrations of His–PDK1
alone (about 30 U/mg; Figure 4a). In contrast, the mutant
form of PKBα in which the Ser473 phosphorylation site is
mutated to aspartic acid (GST–S473D PKBα) was acti-
vated to the same maximum specific activity by either
PDK1 or PIF plus PDK1 (Figure 4b). These findings
raised the possibility that GST–PIF plus PDK1 had
induced phosphorylation of PKBα at Ser473, as well as
Thr308. In order to investigate this possibility, we pre-
pared phospho-specific antibodies (termed P-473) that
recognise only PKBα that has been phosphorylated at
Ser473. These antibodies did not recognise GST–PKBα
that had been incubated with GST–PIF and Mg–ATP in
the absence of PtdIns(3,4,5)P3 or PtdIns(3,4)P2, nor did
PKBα become phosphorylated under these conditions
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Figure 3
Mapping the residues on PIF that are required for interaction with
PDK1. (a) Cells were transiently transfected with DNA constructs
expressing either wild-type GST–PIF or the indicated point mutants of
this protein. The 293 cells were lysed and the GST fusion proteins
purified by affinity chromatography on glutathione–Sepharose beads.
Each GST-fusion protein was incubated for 30 min at 30°C with
GST–S473D PKBα and Mg–ATP in the presence or absence of
phospholipid vesicles containing 10 µM 1,2-SAD-PtdIns(3,4,5)P3, and
the increase in specific activity of GST–S473D PKBα was determined
relative to a control incubation in which the GST fusion protein was
omitted. The basal activity of GST–S473D PKBα was 3.5 U/mg. Each
protein (2 µg) was electrophoresed on a 10% SDS–polyacrylamide gel
and either immunoblotted using an anti-PDK1 antibody raised against
whole protein to detect any endogenous PDK1, or stained with
Coomassie blue to establish the level of expression of the GST–PIF
protein. Similar results were obtained in five separate experiments using
two or more preparations of the wild-type and mutant GST–PIF
proteins. The single letter amino-acid code is used in construct names.
(b) Yeast harbouring the pAS2-1 wild-type PDK1 vector (PDK1 vector)
or the empty pAS2-1 vector (vector) were transformed with pGAD10
plasmid coding for the expression of the wild-type PIF or the indicated
mutants of PIF. The resulting yeast strain was grown on SD –Leu –Trp
–Ura –His +3-AT medium, which permits growth of only yeast
constructs in which GST–PIF and PDK1 are capable of interacting.
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(Figure 4c). Following the addition of PtdIns(3,4,5)P3 or
PtdIns(3,4)P2, however, GST–PKBα became strongly
phosphorylated and recognised by the P-473 antibody.
Incubation of the P-473 antibody with the phosphory-
lated Ser473 peptide immunogen used to raise the anti-
body (but not with the dephosphorylated peptide, or a
phosphopeptide corresponding to the sequence sur-
rounding Thr308) abolished its recognition of
GST–PKBα (Figure 4c). In contrast, a much higher con-
centration of His–PDK1 that was not bound to PIF
induced no phosphorylation of Ser473 in the presence or
absence of PtdIns(3,4,5)P3.
To identify the residue(s) in PKBα that are phosphory-
lated by the GST–PIF plus PDK1 complex, the 32P-
labelled GST–PKBα was digested with trypsin and
chromatographed on a C18 column [14]. Two major 32P-
labelled peptides were observed that eluted at 24% and
26% acetonitrile (Figure 4d). These peptides co-eluted
with the 32P-labelled tryptic peptides containing the
residues Ser473 and Thr308, respectively [14,18], and the
identity of these peptides and the location of the phospho-
rylated residues (Thr308 and Ser473) was established by
matrix associated laser desorption ionization and time of
flight mass spectrometry (MALDI-TOF MS) and solid
phase amino-acid sequencing (data not shown). 
The PtdIns(3,4,5)P3-dependent phosphorylation of PKBα at
Ser473 is mediated by PDK1
The results presented in Figure 4 could be explained in
two different ways. Firstly, the interaction of PIF with
PDK1 might have allowed the latter to phosphorylate
Ser473 as well as Thr308. Secondly, purified GST–PIF
might be complexed to two different protein kinases,
namely PDK1 and PDK2. In order to distinguish between
these possibilities we immunodepleted the PDK1 from
GST–PIF using two different antibodies. We then tested
the ability of the supernatant to phosphorylate PKBα at
Ser473. Strikingly, both PDK1 antibodies completely
removed all the Ser473 kinase activity associated with
GST–PIF (Figure 5a) as well as removing the Thr308
kinase activity (data not shown). A peptide immunogen to
which one of the antibodies was raised prevented immun-
odepletion of the PDK2 activity associated with PIF
(Figure 5a).
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Figure 4
Incubation of PIF with PKBα induces phosphorylation of PKBα at both
Thr308 and Ser473. (a) GST–PKBα or (b) GST–S473D PKBα was
incubated at 30°C for 1 h with Mg–ATP in the presence of either
His–PDK1 (0.1 µg) or GST–PIF purified from 293 cells, which is
associated with endogenous PDK1 (1 µg; termed PIF + PDK1), in the
presence or absence of phospholipid vesicles containing 10 µM 
1,2-SAD-PtdIns(3,4,5)P3. The increase in specific activity of
GST–PKBα was determined relative to a control incubation in which
His–PDK1 or GST–PIF was omitted (average for six determinations,
two independent experiments). The basal activity of GST–PKBα was
1.0 U/mg, and of GST–S473D PKBα was 3.5 U/mg. Under the
conditions used, GST–PKBα (a) and GST–S473D PKBα (b) were
activated maximally because no further increase occurred if the
incubation period was prolonged or by increasing the concentration of
His–PDK1 or GST–PIF. (c) GST–PKBα was incubated with GST–PIF
plus PDK1 (1.0 µg) as in (a), in the presence or absence of
phospholipid vesicles containing 10 µM 1,2-SAD-PtdIns(3,4,5)P3, 
C16-PtdIns(3,4,5)P3 or C16-PtdIns(3,4)P2 (where C16 stands for
DiC16:0 dipalmitoyl). The reactions were terminated with 1% SDS, the
samples subjected to SDS–PAGE and immunoblotted using the 
P-473 antibody incubated in the presence or absence of the synthetic
peptides (all at 10 µg/ml) corresponding to residues 467–477 of
PKBα phosphorylated at Ser473 (phospho-473 peptide), the same
peptide but not phosphorylated (de-phospho-473 peptide), and a
peptide corresponding to residues 301–313 of PKBα phosphorylated
at Thr308 (phospho-308 peptide). (d) As in (a), except that radioactive
Mg–[γ-32P]ATP (106 cpm per nmol) was employed, the samples
alkylated with 4-vinylpyridine, electrophoresed on a 10%
polyacrylamide gel, and the phosphorylated GST–PKBα was digested
with trypsin and applied to a C18 column as described previously [19].
The 32P-labelled peptides were identified by mass spectrometry and
Edman sequencing as the PKBα tryptic peptides phosphorylated at
Ser473 and Thr308, respectively.
These results indicated that the PtdIns(3,4,5)P3-depen-
dent Ser473 kinase activity associated with GST–PIF was
catalysed by PDK1 rather than by a separate enzyme.
Consistent with this notion, all the mutant GST–PIF pro-
teins purified from 293 cells that were able to interact with
the endogenous PDK1 (Figure 3) were able to induce the
phosphorylation of PKBα at Ser473 (Figure 5b). In con-
trast, the point mutations in GST–PIF that abolish its
association with PDK1 also prevented the phosphorylation
of PKBα at Ser473 (Figure 5b).
Conversion of PDK1 into a kinase that phosphorylates
Thr308 and Ser473 of PKBα
It could still be argued that the phosphorylation of Ser473
was catalysed by a protein kinase that is distinct from
PDK1, but that this kinase was tightly complexed with
PDK1 and not dissociated by chaotrophic reagents or
detergents, and that this kinase was therefore also removed
from GST–PIF by immunodepletion of PDK1. In order to
address this point, we removed PDK1 from purified
GST–PIF by immunodepletion and added the PDK1-
depleted PIF (termed GST–PIF*) to purified wild-type
GST–PDK1 (see Supplementary material) or His–PDK1
(data not shown). This converted PDK1 from a kinase that
phosphorylates PKBα at Thr308 only, to a kinase that
phosphorylates Ser473 as well as Thr308 in a
PtdIns(3,4,5)P3- or PtdIns(3,4)P2-dependent manner (see
Supplementary material). Initial-rate studies demonstrated
that, under the conditions used, the GST–PIF*–PDK1
complex phosphorylates Thr308 of PKBα at twice the rate
that it phosphorylates Ser473 (data not shown). Moreover,
the ability of GST–PIF* to convert PDK1 into a Ser473
kinase was dependent upon PDK1’s catalytic activity,
since a catalytically inactive GST–PDK1 mutant was not
capable of phosphorylating PKBα at Ser473 in the pres-
ence of GST–PIF* (see Supplementary material).
The above experiments do not exclude the possibility that
another protein associated with PIF (rather than PIF itself)
might be capable of interacting with PDK1 and altering its
substrate specificity. This possibility was eliminated by the
demonstration that a 24 residue synthetic peptide corre-
sponding to region B of PIF was capable of inducing
His–PDK1 to phosphorylate PKBα at Ser473 in a 3-phos-
phoinositide-dependent manner (Figure 6). In contrast, a
region B peptide in which Asp978 was mutated to alanine
was far less effective at inducing this alteration in the speci-
ficity of PDK1 than the nonmutated peptide. The region B
peptide converts the wild-type GST–PDK1, but not the
kinase-dead GST–PDK1, into a kinase that can phosphory-
late Ser473 (data not shown). Also, GST–PDK1 expressed
in bacteria was capable of phosphorylating GST–PKBα at
Ser473 in the presence of the region B peptide and
PtdIns(3,4,5)P3 (data not shown), indicating that no other
protein kinase expressed in eukaryotic cells which might
be associated with PDK1 is required for this reaction.
Lipid specificity of Ser473 phosphorylation
We compared the ability of a panel of PtdIns derivatives
to stimulate the phosphorylation of Thr308 and Ser473 by
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Figure 5
The ability of GST–PIF to phosphorylate
PKBα at Ser473 is dependent upon the
presence of PDK1. GST–PIF purified from
293 cells, which is associated with
endogenous PDK1 (20 µg in 50 µl), was
incubated with protein-G–Sepharose (10 µl)
conjugated to an anti-MSK1 antibody A [42]
(5 µg, non-specific antibody), an anti-PDK1
antibody raised against the whole protein
(5 µg), an anti-PDK1 peptide antibody raised
against the 16 carboxy-terminal amino acid
residues of PDK1 (5 µg, peptide antibody) or
no antibody (control) in the presence or
absence of the PDK1 carboxy-terminal peptide
immunogen (0.2 mM). After incubation on a
shaking platform for 60 min at 4°C, the
suspension was centrifuged and GST–PIF in
the supernatant (2.0 µg) was incubated with
GST–PKBα and Mg–ATP for 60 min at 30°C
in the presence or absence of phospholipid
vesicles containing 10 µM 1,2-SAD-
PtdIns(3,4,5)P3, C16-PtdIns(3,4,5)P3 or C16-
PtdIns(3,4)P2. The reactions were terminated
by making the solutions 1% in SDS, and the
samples were subjected to SDS–PAGE and
immunoblotted using the P-473 antibody.
Identical results were obtained in two separate
experiments. (b) The wild-type and mutant
GST–PIF proteins (2.0 µg) used in Figure 3
were incubated with GST–PKBα and
Mg–ATP for 60 min at 30°C in the presence
or absence of lipid vesicles containing 10 µM
1,2-SAD-PtdIns(3,4,5)P3, and the degree of
phosphorylation of PKBα at Ser473 was
established by immunoblotting. Similar results
were obtained in four separate experiments
using two different preparations of the wild-
type and mutant GST–PIF proteins.
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H913A P932A F946A T951A Q971A F974A R975A D976G F977A D978A D978S Y979AIdentity of mutants
the GST–PIF plus PDK1 complex. Synthetic sn-1-
stearoyl, 2-arachidonoyl D-PtdIns(3,4,5,)P3 (1,2-SAD-
PtdIns(3,4,5)P3), the predominant form of PtdIns(3,4,5)P3
that occurs naturally (lipid 8, Figure 7), and synthetic 2,3-
SAD-PtdIns(3,4,5,)P3 (lipid 10, Figure 7) were highly
effective in inducing both the phosphorylation of
GST–PKBα at Ser473 (Figure 7b) and the phosphoryla-
tion of Thr308 (measured by the activation of
GST–S473D PKBα), indicating that the enantiomeric
configuration of the glycerol moiety is not an important
determinant of specificity. The L enantiomers of these
lipids (lipids 9 and 11, Figure 7) failed to induce a signifi-
cant phosphorylation of PKBα at Ser473 or activation of
GST–S473D PKBα. Rac-1,2-dilinoleoyl phosphatidyl D/L-
myo-inositol 3,4,5-trisphosphate (linoleic acid is C18:2;
lipid 7, Figure 7), sn-1,2-dipalmitoyl D-PtdIns(3,4,5)P3
(lipid 6, Figure 7) or sn-1,2-dipalmitoyl PtdIns(3,4)P2
(lipid 3, Figure 7) were also effective at inducing the PIF
plus PDK1 complex to phosphorylate PKBα at Ser473 and
Thr308. PtdIns-3P (lipid 2, Figure 7), PtdIns(3,5)P2 (lipid
4, Figure 7) and PtdIns(4,5)P2 (lipid 5, Figure 7), however,
did not induce the PIF plus PDK1 complex to phosphory-
late PKBα at Ser473 or Thr308. In the absence of the PIF
plus PDK1 complex, none of the PtdIns derivatives tested
induced any phosphorylation of PKBα (data not shown).
Maximal activation of PKBα by PDK1 plus PIF requires
PtdIns(3,4,5)P3 to interact with PDK1
Although PDK1 binds to PtdIns(3,4,5)P3 with high affinity
through its PH domain, this interaction does not influence
its ability to activate a PKB mutant lacking the PH domain
[20,31]. This is confirmed in Figure 8, which shows that
the rate at which His–PDK1 phosphorylates and activates a
mutant form of PKBα lacking the PH domain (GST–∆PH
PKBα) is the same in the presence or absence of
PtdIns(3,4,5)P3 (Figure 8a). Intriguingly, the addition of
GST–PIF* to His–PDK1 halves the rate at which PDK1
activates GST–∆PH PKBα in the absence of
PtdIns(3,4,5)P3. The addition of PtdIns(3,4,5)P3 results in
a 3–4-fold enhancement of the rate at which His–PDK1
plus GST–PIF* can activate GST–∆PH PKBα (Figure 8a).
Furthermore, the GST–PIF plus PDK1 complex purified
from 293 cells also activates GST-∆PH PKBα at an approx-
imately fourfold higher rate in the presence of either
PtdIns(3,4,5)P3 or PtdIns(3,4)P2 than in their absence.
PtdIns(4,5)P2 or PtdIns(3)P do not increase the rate at
which the GST–PIF plus PDK1 complex phosphorylates
GST–∆PH PKBα (Figure 8b).
Identification of a PtdIns(3,4,5)P3-dependent Ser473 kinase
activity as PDK1
We fractionated rat brain extracts by batchwise chro-
matography on Q-Sepharose, followed by gradient
elution from heparin–Sepharose (see Materials and
methods). As reported previously [19], PDK1 (assayed as
a PtdIns(3,4,5)P3-dependent enzyme that activates
GST–S473D PKBα) was eluted from heparin–Sepharose
as a broad peak at 0.75M NaCl (Figure 9a). A
PtdIns(3,4,5)P3-dependent PDK2 activity that phospho-
rylated PKBα at Ser473 was also identified in the
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Figure 6
Conversion of PDK1 into an enzyme that can
phosphorylate both Thr308 and Ser473 of
PKB by addition of a synthetic peptide.
(a) His–PDK1 (20 ng) was incubated in the
presence or absence of the following
peptides (all at 20 µM); region B peptide,
residues 969–984 of PIF; D978A region B
peptide, in which Asp978 is mutated to
alanine; or region A peptide, residues
927–951 of PIF. After allowing to stand for
1 h at 4°C, GST–PKBα, Mg–ATP and the
indicated phospholipid vesicles containing
either 10 µM 1,2-SAD-PtdIns(3,4,5)P3, C16-
PtdIns(3,4,5)P3 or C16-PtdIns(3,4)P2 were
added. After 1 h at 30°C, the reactions were
terminated by making the solutions 1% in
SDS, following which the samples were
subjected to SDS–PAGE and immunoblotted
using the P-473 antibody. Identical results
were obtained in three separate experiments.
(b–d) His–PDK1 was incubated for 1 h on ice
as above in the presence of (b) region B
peptide, (c) D978A region B peptide or (d) no
peptide and then incubated with
Mg–[γ-32P]ATP and phospholipid vesicles
containing 10 µM 1,2-SAD-PtdIns(3,4,5)P3.
After 1 h at 30°C, the reactions were
terminated and the residues on PKBα that
became phosphorylated under these
conditions were established as described in
the legend to Figure 4.
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heparin–Sepharose eluate, and this was present in the
tailing half of the PDK1 activity (Figure 9a). The peak
containing the PDK2 activity (fractions 7 and 8) was
pooled, PDK1 removed by immunoprecipitation and the
supernatant re-assayed for PDK1 and PDK2 activity.
Strikingly, the antibody completely removed not only the
PDK1 (Thr308 kinase) activity but also the PDK2
(Ser473 kinase) activity (Figure 9b). This result indicates
that a fraction of the PDK1 in the heparin–Sepharose
eluate possesses PDK2 activity.
Discussion
Most of the PDK1 substrates identified to date, apart from
PKA, possess a PDK2 consensus motif about 160 residues
carboxy-terminal to the PDK1 phosphorylation site. Phos-
phorylation of both the PDK1 and PDK2 sites is required
for maximal activation of PKB and p70 S6 kinase and/or for
stability of PKC isoforms [32]. In this paper, we demon-
strate that the kinase domain of PDK1 interacts specifically
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Figure 7
Lipid specificity of phosphoinositide-dependent PIF plus PDK1-induced
phosphorylation of Thr308 and Ser473 of PKBα. GST–PKBα was
incubated for 60 min at 30°C with GST–PIF (1.0 µg) purified from 293
cells (which is associated with endogenous PDK1, see Figure 3),
Mg–ATP and phospholipid vesicles containing various PtdIns lipids
(numbered 1–11, see below) all at a final concentration of 10 µM in the
assay. (a) The reactions were terminated by the addition of Triton 
X-100 [19] and the increase in specific activity of GST–S473D PKBα
(in U/mg) determined, relative to a control incubation in which the
GST–PIF plus PDK1 complex was omitted (average for six
determinations, two independent experiments). The basal activity of
GST–S473D PKBα was 3.5 U/mg. (b) The reactions were terminated
by making the solutions 1% in SDS, the samples were subjected to
SDS–PAGE and the extent of PKBα phosphorylation was established
using the phospho-specific antibody that recognises PKBα
phosphorylated at Ser473. In (b) the results of two separate
experiments with different preparations of lipid are shown. Lipid 1,
buffer control; lipid 2, PtdIns 3P; lipid 3, sn-1,2-dipalmitoyl
PtdIns(3,4)P2; lipid 4, PtdIns(3,5)P2; lipid 5, PtdIns(4,5)P2; lipid 6, 
sn-1,2-dipalmitoyl D-PtdIns(3,4,5)P3; lipid 7, rac-1,2-dilinoleoyl
phosphatidyl D/L-myo-inositol 3,4,5-trisphosphate; lipid 8, 1,2-SAD-
PtdIns(3,4,5)P3; lipid 9, sn-1-stearoyl, 2-arachidonoyl L-PtdIns(3,4,5)P3;
lipid 10, sn-2-stearoyl, 3-arachidonoyl D-PtdIns(3,4,5)P3; lipid 11, 
sn-2-stearoyl, 3-arachidonoyl L-PtdIns(3,4,5)P3.
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Figure 8
PDK1 complexed to PIF is directly activated by PtdIns(3,4,5)P3.
(a) GST–∆PH PKBα was incubated at 30°C for 1 h with Mg–ATP in
the presence of either buffer (control), His–PDK1 (0.1 µg), or
His–PDK1 (0.1 µg) plus GST–PIF* (1.0 µg, from which all the PDK1
had been removed by immunodepletion), or GST–PIF* alone (1.0 µg)
in the presence or absence of phospholipid vesicles containing 10 µM
1,2-SAD-PtdIns(3,4,5)P3. (b) GST–PIF purified from 293 cells, which
is associated with endogenous PDK1 (2 µg, termed PIF–PDK1), was
incubated with GST–∆PH PKB as in (a), with the indicated
phosphoinositides (10 µM). The increase in specific activity of
GST–∆PH PKBα was determined, relative to a control incubation in
which His–PDK1 or GST–PIF was omitted. The basal activity of
GST–∆PH PKBα was 3.0 U/mg. The average results for a single
experiment performed in triplicate are shown; similar results were
obtained in three other separate experiments.
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with a modified PDK2 phosphorylation consensus motif
present at the carboxyl terminus of PRK2, in which the
phosphorylated serine or threonine residue is replaced by
an aspartic acid (Asp978). Mutation of any of the conserved
aromatic residues in the PDK2 consensus sequence to
alanine, or mutation of Asp978 to alanine or serine, com-
pletely abolished the interaction of PDK1 with PIF
(Figure 3).
PRK2 itself is likely to be a substrate for PDK1 as it pos-
sesses a perfect PDK1 consensus sequence between sub-
domains VII and VIII of the kinase domain
(TFCGTPEFL, in single letter amino acid code where the
italicised threonine residue corresponds to Thr816, the
putative site of PDK1 phosphorylation). In the case of
PRK2, it is possible that the role of the PIF domain is to
interact directly with PDK1, ensuring that Thr816 is phos-
phorylated efficiently by PDK1. As PRK2 [30] (and its
close relative PRK1 [33,34]) might be dependent on the
GTPase Rho for activity, it is possible that the interaction
between PRK2 and Rho complexed to GTP is also
required for the phosphorylation of PRK2 by PDK1 to take
place. One scenario is that the carboxyl terminus of PRK2
is exposed upon the formation of a complex between
PRK2 and Rho–GTP. This may enable interaction with,
and phosphorylation by, PDK1, leading to the activation of
PRK2. PRK2 is, however, known to become proteolysed
during apoptosis as a result of cleavage by caspase-3 imme-
diately carboxy terminal to Asp117 and Asp700 [35]. PRK2
is highly susceptible to proteolysis when purified or over-
expressed in cells [36]. One possibility therefore is that a
carboxy-terminal fragment of PRK2, that is devoid of any
catalytic activity, is present in cells, and that this interacts
with PDK1. It is also possible that a fragment of PRK2 may
be generated by an alternative splicing mechanism or by
the use of alternative promoters. Future work will need to
address whether PDK1 is complexed with PRK2 or  frag-
ments of this enzyme in intact cells.
SGK and the p70 S6 kinase are far better substrates for
PDK1 if the PDK2 phosphorylation site is mutated to an
acidic residue [17,26,27]. Thus, PDK1 might be able to
interact directly with SGK or the p70 S6 kinase when the
PDK2 site is phosphorylated, enabling PDK1 to phospho-
rylate these enzymes at the PDK1 site in the activation
loop. Future work will need to address whether or not
PDK1 complexed with another protein is capable of induc-
ing phosphorylation of the PDK2 site of these enzymes.
A catalytically inactive mutant of PKBα becomes phos-
phorylated at Ser473 in response to insulin, whereas
PKBα phosphorylated at Thr308 alone does not become
phosphorylated at Ser473 in vitro upon incubation with
Mg–ATP in the presence of PtdIns(3,4,5)P3 [14,19].
These observations indicate that phosphorylation of
PKBα at Ser473 is unlikely to be an autophosphorylation
event catalysed by PKBα itself. We have reported previ-
ously that Ser473 is phosphorylated in vitro by MAP
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Figure 9
(a) Brain extract was fractionated by batchwise chromatography on
Q-Sepharose followed by gradient elution from heparin–Sepharose (see
Materials and methods). The column fractions were assayed for their
ability to phosphorylate PKBα at Thr308 (measured by the increase in
GST–S473D PKBα activity) and Ser473 (using the P-473 antibody), in
the presence (open squares) or absence (closed squares) of 10 µM
1,2-SAD-PtdIns(3,4,5)P3. The broken line indicates the salt gradient.
(b) Fractions 7 and 8 of the heparin–Sepharose column were pooled
and aliquots (0.1 ml) incubated with protein-G–Sepharose (10 µl)
conjugated to an MSK1 antibody A [42] (5 µg; non-specific antibody),
an anti-PDK1 antibody raised against the whole protein (5 µg), or no
antibody (control). After incubation on a shaking platform for 60 min at
4°C, the suspension was centrifuged, and an aliquot of the supernatant
(5 µl) incubated for 60 min at 30°C with either GST–S473D PKBα
(PDK1 assay) or GST–PKBα (PDK2 assay) and Mg–ATP in the
presence or absence of 10 µM 1,2-SAD-PtdIns(3,4,5)P3 or C16-
PtdIns(3,4)P2. The phosphorylation of PKBα at Ser473 and Thr308 was
then measured as in (a). Similar results were obtained in experiments
from two separate purifications. The PDK2 activity was also
immunoprecipitated using an anti-PDK1 peptide antibody raised against
the 16 carboxy-terminal residues of PDK1 (data not shown).
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kinase-activated protein kinase-2 (MAPKAP-K2) [14], but
this enzyme does not mediate the phosphorylation of
Ser473 in vivo in response to insulin, insulin-like growth
factor 1 (IGF1), heat shock or hydrogen peroxide [37].
Furthermore, the phosphorylation of PKBα at Ser473 by
MAPKAP-K2 in vitro is not dependent upon the presence
of PtdIns(3,4,5)P3 [14]. It has also been claimed that the
integrin-linked kinase (ILK) is capable of phosphorylating
Ser473 of PKBα in vitro [38]. We have thus far not been
able to demonstrate that ILK phosphorylates Ser473 of
PKBα (S. Dowler and D.R.A., unpublished observations).
Indeed, it is uncertain as to whether ILK is actually an
active protein kinase, as it lacks certain motifs found in
every other protein kinase. It has also been claimed that
mTOR (mammalian target of rapamycin) can phosphory-
late the PDK2 site of p70 S6 kinase [39]. We have been
unable to reproduce this finding and furthermore were
unable to phosphorylate PKBα at Ser473 with mTOR
(D.R.A. and P. Shepherd, unpublished observations).
Given that the insulin/IGF1-induced phosphorylation of
Ser473, like that of Thr308, is prevented by inhibitors of PI
3-kinase, it is likely that phosphorylation of Ser473 is also
catalysed by a PtdIns(3,4,5)P3-dependent protein kinase.
In this study we have made the surprising observation that
the interaction of PIF with the kinase domain of PDK1
converts PDK1 from an enzyme that only phosphorylates
PKBα at Thr308 to a form that phosphorylates both
Thr308 and Ser473 in a PtdIns(3,4,5)P3- and
PtdIns(3,4,)P2-dependent manner. The requirement for
PtdIns(3,4,5)P3 or PtdIns(3,4,)P2 is extremely specific,
because only the D enantiomers of PtdIns(3,4,5)P3 are
effective, and many other PtdIns phospholipids, including
PtdIns(4,5)P2, are ineffective. The residues that surround
Thr308 and Ser473 are distinct, the only common feature
being an aromatic residue immediately carboxy terminal to
the phosphorylation site. This suggests that PDK1 pos-
sesses two distinct specificities when complexed with PIF.
If a mutant of PKBα lacking the PH domain (which cannot
therefore interact with PtdIns(3,4,5)P3) is expressed in cells,
it nevertheless undergoes a wortmannin-sensitive activation
and phosphorylation at Thr308 and Ser473 [40]. This
implies that PDK1 is activated by PtdIns(3,4,5)P3 in vivo.
PDK1 that is isolated from either control or insulin-stimu-
lated cells has similar activity towards GST–∆PH PKBα
[20,27]. Furthermore, experiments in vitro demonstrated
that despite binding to PtdIns(3,4,5)P3/PtdIns(3,4)P2,
through its PH domain [22,41], these 3-phosphoinositides
have no influence on the rate at which PDK1 phosphory-
lates ∆PH PKBα, p70 S6 kinase or SGK; substrates that do
not interact with 3-phosphoinositides [3,17,18]. Impor-
tantly, the interaction with PIF confers on PDK1 the ability
to be activated directly by PtdIns(3,4,5)P3/PtdIns(3,4)P2 in
vitro (Figure 8). This does not happen if the PH domain of
PDK1 is deleted (data not shown). 
Stokoe et al. [21] observed that a PDK1-like activity
obtained after chromatography of a brain extract on a
MonoQ column activated ∆PH PKBα at a threefold higher
rate in the presence of PtdIns(3,4,5)P3 than in its absence.
It is possible that the partially purified PDK1 used in
these experiments was complexed with a PIF-like protein.
This subunit might have been lost during subsequent
purification of the protein.
The results presented in this paper raise the strong possi-
bility that PDK1 itself might be the enzyme responsible
for mediating the phosphorylation of PKBα at both
Thr308 and Ser473. It is possible that PRK2, a fragment of
PRK2, or a related peptide/protein(s), might interact with
the PDK1, converting it into an enzyme that can phospho-
rylate both Ser473 and Thr308 of PKBα, as well as permit-
ting the direct activation of PDK1 by PtdIns(3,4,5)P3.
Consistent with this hypothesis, we have identified a
PtdIns(3,4,5)P3-dependent Ser473 kinase activity in brain
that is immunoprecipitated with a PDK1-specific antibody
(Figure 9). This form of PDK1 might be complexed to
PRK2 or its carboxy-terminal fragment or to another
peptide or protein with similar properties.
Conclusions
This study provides the first evidence that PDK1 and
PDK2 might be the same enzyme and that the specificity
of this enzyme for two different phosphorylation sites on
PKBα might be modulated by the interaction with one or
more accessory proteins. Our results also suggest that
when PDK1 interacts with molecules such as PIF its
activity may become directly stimulatable by the inter-
action of the PH domain of PDK1 with PtdIns(3,4,5)P3
or PtdIns(3,4)P2.
Materials and methods
Materials
The yeast two-hybrid human skeletal muscle library (in pGAD10 vector)
and the pAS2-1 vector were purchased from Clontech. Expression
constructs for GST–PKBα [19], GST–PDK1, Myc–PDK1 and other
mutants of PDK1 [20], GST–p90 RSK1 [42], GST–MSK1 [42] and
GST–p70 S6 kinase lacking the carboxy terminal 104 residues [26]
were generated as described previously. Synthesis of 1,2-SAD-
PtdIns(3,4,5)P3 and its stereoisomers is described [43]; all lipids were
obtained from sources described previously [19]. All the experiments
using 3-phosphoinositides were carried out in the presence of phos-
pholipids containing 100 µM phosphatidylcholine and 100 µM phos-
phatidylserine. Information regarding antibodies and other reagents as
well as preparation of His–PDK1 used in this study is given in the Sup-
plementary material.
Buffer solutions
Buffer A consists of 50 mM Tris-HCl pH 7.5, 1 mM EGTA, 1 mM
EDTA, 1% (by mass) Triton X-100, 1 mM sodium orthovanadate,
50 mM sodium fluoride, 5 mM sodium pyrophosphate, 0.27 M sucrose,
1 µM microcystin-LR, 0.1% (by volume) β-mercaptoethanol and ‘com-
plete’ proteinase inhibitor cocktail (one tablet per 25 ml, Boehringer
Mannheim). Buffer B consists of 50 mM Tris-HCl pH 7.5, 0.1 mM
EGTA and 0.1% (by volume) β-mercaptoethanol. Buffer C consists of
50 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.27 M sucrose
and 0.1% (by volume) β-mercaptoethanol.
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Myc-tagged human PDK1, the kinase domain of PDK1 (residues
1–404) and the PH domain of PDK1 (428–556) were subcloned into
EcoRI–SalI of the yeast pAS2-1 vector. A yeast two-hybrid screen was
carried out using a human skeletal muscle library subcloned into the
pGAD10 vector (Clontech) transformed into the yeast strain Y166.
Yeast cells (4 × 106) were transformed with pGAD10 library constructs
and PDK1 constructs in the pAS2-1 vector. Further information on the
yeast two-hybrid screen is provided in the Supplementary material. The
expression of all GST fusion proteins in 293 cells was performed as
described previously ([19] and see Supplementary material).
Measurement of PKBα activation after incubation with GST–PIF
This assay was carried out in two stages as described previously ([19],
and see Supplementary material). Briefly, in the first stage, GST–PKBα
was incubated with GST–PIF (or other indicated PDK1 proteins in the
presence or absence of peptides) in the presence of Mg–ATP and
phospholipid vesicles. In the second stage, the solution was made
0.5% (by volume) in Triton X-100 (which completely inhibits phospho-
rylation of GST–PKBα without affecting GST–PKBα activity [19])
together with Mg–[γ-32P]ATP, and the specific PKBα substrate peptide
substrate RPRTAAF [44].
Phosphorylation of GST–PKBα by incubation with GST–PIF
In experiments in which the phosphorylation of PKBα was determined,
using the phospho-specific Ser473 PKBα antibodies (P-473), the
incubations were identical to the first stage described above except
that the reactions were terminated by the addition of 1% (by mass)
SDS and immunoblotting carried out as described in the Supplemen-
tary material. In experiments in which the sites of phosphorylation on
PKBα were determined, the incubations were identical to the first
stage  described above except [γ-32P]ATP (1000–2000 cpm/pmol)
was used instead of unlabelled ATP. The reactions were stopped by
the addition of SDS and β-mercaptoethanol to final concentrations of
1% (by mass) and 1% (by volume) respectively, and heated for 5 min at
95oC, and the residues in PKBα that are phosphorylated determined
as described previously [14,19].
Partial purification of PDK2 from rat brain
Ten rats were killed with CO2, and the brains rapidly extracted and
homogenised in 50 ml ice-cold Buffer A. After centrifugation for 30 min
at 25 000 × g, the supernatant was filtered through a 0.44 micron filter
and applied to a 5 ml HiTrap Q-Sepharose column equilibrated in
buffer C. The column was washed with 100 ml buffer C containing
0.1 M NaCl, and then eluted with 30 ml of buffer C containing 0.3 M
NaCl. The eluate was diluted to 0.2 M NaCl in buffer C, and applied
directly on to a 1 ml heparin–Sepharose column (HiTrap) equilibrated
in buffer C containing 0.2 M NaCl. The column was developed with a
20 ml linear salt gradient to 2.0 M NaCl at a flow rate of 1 ml/min and
fractions of 1 ml were collected. 
Supplementary material
Additional methodological detail and two figures showing quantitative
analysis of the binding of PDK1 to PIF and using GST–PIF* to convert
PDK1 into an enzyme that can phosphorylate both Thr308 and Ser473
of PKB are published with this paper on the internet. 
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